compound glp 1 pharmacy Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market After Novo and Lilly resolved

1f and 3a

This is one of the reasons I do not reduce the dose in the early post-operative period

From unpleasant gastrointestinal side effects to serious side effects like thyroid cancer and pancreatitis, understanding the whole picture is essential

When mere food intake seems inadequate, these injectables boost your energy and mood

Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results